| Time |
Presentation Title |
Speaker |
| Main venue (Ballroom A-B-C) |
Chairman: Shengli Yang, Chingli Hu, Kurt Zatloukal, Bartha Maria Knoppers |
| 09:00-09:30 |
Welcome |
Shengli Yang |
| |
| S1: Translational Medicine & Biobank |
Chairman: Shengli Yang, Kurt Zatloukal |
| 09:30-09:50 |
How Biobanks May Contribute to Innovation |
Kurt Zatloukal |
| 09:50-10:10 |
The application of Biobanking in Clinic: Biomarkers for Kidney Disease |
Zhihong Liu |
| 10:10-10:30 |
Biobankonomics: Developing a Sustainable Biospecimen Resource |
Jim Vaught |
| 10:30-10:45 |
Tea Break & Group Photo |
| 10:45-11:05 |
Rules of Biospecimen Resource Usage in China |
Yanrong Sun |
| 11:05-11:25 |
Towards Global Sharing of Genomic and Clinical Data |
Bartha Maria Knoppers |
| 11:25-11:45 |
Ethics Guideline for Shanghai Clinical Biobank |
Chingli Hu |
| 11:45-12:00 |
Discussion |
| |
| S2: Cohort studies for biobanks |
Chairman: Chingli Hu, Bartha Maria Knoppers |
| 14:00-14:15 |
Shanghai Birth Cohort Study |
Jun Zhang |
| 14:15-14:30 |
Cohort Study of Kodorrie Biobank |
Zhengming Chen |
| 14:30-14:45 |
Exploration of Biobank Construction in Taiwan |
Chen-Yang Shen |
| 14:45-15:00 |
Cohort Study in Columbia University |
Deliang Tang |
| 15:00-15:15 |
Tea Break |
| 15:15-15:30 |
Construction of National Cardiovascular Biobank |
Lixin Jiang |
| 15:30-15:45 |
Gene & Environment: Prospective Cohort Study of Epidemics |
Xu Lin |
| 15:45-16:00 |
Population-Based Cohort Study in Taizhou |
Xiaofeng Wang |
| 16:00-16:15 |
Canada Child Birth Cohort Study |
William Fraser |
| 16:15-16:30 |
Discussion |
| Time |
Presentation Title |
Speaker |
>
| S3: Disease studies for biobanks |
Chairman: Jim Vaught, Jiayou Chu |
| 09:00-09:15 |
Role of Government and Society in Biobanking |
Kan Zhang |
| 09:15-09:30 |
The story of Beijing Biobank |
Peng Wang |
| 09:30-09:45 |
Exploration of Major Disease-Based Biobank Development in Shanghai |
Peiyong Zheng |
| 09:45-10:00 |
Implementing a State-of-the-Art Biorepository: The Genome Quebec-Chicoutimi Hospital Experience |
Steve Arsenault |
| 10:00-10:15 |
Tea Break |
| 10:15-10:30 |
Biobank & Data Base for Liver Cancer |
Weiping Zhou |
| 10:30-10:45 |
Study of Susceptibility Genes: the Use of Rheumatism Bio-Samples |
Huji Xu |
| 10:45-11:00 |
The Biobank of Neurology |
JinSong Wu |
| 11:00-11:15 |
Cancer Biobank: Facility Management and Services |
Lianhai Zhang |
| 11:15-11:30 |
Discussion |
| |
| S4: Quality management systems for biobanking |
Chairman: Geogers Dagher, Yong Zhang |
| 14:00-14:15 |
Proficiency Testing (PT) Project of ISBER & Biobank |
Andy Zaayange |
| 14:15-14:30 |
Quality & Value in Biobanks |
Mark Divers |
| 14:30-14:45 |
Toward the Establishment of Indicators for Evaluating Hospital-Integrated Tumor Biobanks: Main Current Stakes & Limitations |
Paul Holfman |
| 14:45-15:00 |
Data Quality Control of Biobank |
Weiye Wang |
| 15:00-15:15 |
Tea Break |
| 15:15-15:30 |
Quality Perspectives in Biobanking |
Robert Jones |
| 15:30-15:45 |
Quality Control of Nucleic Acid in Biobank |
Yong Zhang |
| 15:45-16:00 |
Establishing a US Compliant Biorepository: Challenges & Successes |
Scott Clark |
| 16:00-16:15 |
Data Management in UK Biobank |
James Brennan |
| 16:15-16:30 |
Discussion |
| 16:30-16:40 |
Closing Ceremony |
